Tag Archives: coronary artery disease

Nickel free, built-in nanotubular drug eluting stents

AoS. Ni-free, built-in nanotubular drug eluting stents

Coronary Artery Disease is a common cause of heart failure. Coronary Artery Disease (CAD) is caused by the accumulation of lipids and fats within an injured arteries’ walls and restricts the blood flow to the heart muscle

A new drug to improve drug-eluting stents in coronary artery disease

Patients with symptomatic coronary artery disease often receive stent treatment in obstructed coronary arteries of the heart. Even though current generation drug-eluting stents perform very well in the short-term, concerns still exist about their long-term efficacy due

Memory process in patients with ischemic left ventricular dysfunction

Heart failure is a complex syndrome characterized by hemodynamic and neuro-hormonal alterations. In recent literature a relationship between heart failure and the presence of cognitive disorders, in particular in the domain of the attentional-executive functions, was reported

EGCg-AuNPs Nanotherapeutics – as an alternative Green Nanotechnology approach for treating cardiovascular diseases

Cardiovascular diseases are the leading cause of morbidity and mortality in the United States and globally. However, despite remarkable technological advances, significant limitations remain in stent-based treatment. Therefore, it is important to develop selective and effective therapeutics

Does the number of platelets affect outcome in patients with acute myocardial infarction?

Coronary artery atherosclerotic disease (CAD) is the most prevalent disease in industrialized countries. Acute ST-elevation myocardial infarction (STEMI) results from sudden obstruction of a coronary artery causing abrupt interruption of blood flow to the myocardium. Nowadays, urgent

Nuclear cardiac imaging: the “old grandma” has still something to say

Ischemic heart disease (IHD) remains one of the most relevant predictors of overall patients’ mortality and a major determinant of sanitary and social costs. Different strategies have been proposed for the early diagnosis of myocardial ischemia, a

A better way to measure heart disease risk for an overweight society

Low density lipoprotein (LDL) cholesterol or the “bad cholesterol” is an established measure of cardiovascular risk. LDL particles interact with the lining of the blood vessel and contribute to cholesterol loading in the arterial wall. Continued buildup